Special Series (Published)

Ovarian Cancer

Posted on
Guest Editor: Heriberto Medina-Franco, MD, FACS. Department of Surgery, Section of Surgical Oncology, National Institute of Medical Sciences and Nutrition “Salvador Zubirán”, Mexico City, Mexico

Neoadjuvant/Adjuvant Treatment for Early Breast Cancer

Posted on
Guest Editors: Yutaka Yamamoto, Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Takayuki Ueno, Breast Surgical Oncology, The Cancer Institute Hospital of JFCR Tokyo, Japan

Sarcoma MDT Series

Posted on
Guest Editor: William W. Tseng, MD. USC Surgical Oncology, 1510 San Pablo Street, HCC-I, Suite 514, Los Angeles, CA 90033, USA.

Meet The Professor

Posted on
The "Meet the Professor" series features interviews with the global Key Opinion Leaders, providing a window into the new developments, breakthroughs, and achievements in the interviewees’ professional fields, both clinically and academically.

Cancer Immunotherapy Column

Posted on
Guest Editors: Bernard A Fox, Robert W Franz Cancer Research Center, Providence Portland Medical Center, Earle A Chiles Research Institute, Portland, Oregon, USA.Shukui Qin. Department of Medical Oncology, PLA Cancer Center, Nanjing Bayi Hospital, Nanjing 210002, China; Wenru Song, MD, PhD. Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, California, USA; Jon M Wigginton, MacroGenics, Inc., 9704 Medical Center Drive, Rockville, MD 20850 USA

Biliary Tract Cancers

Posted on
Guest Editor: Milind Javle, MD, Gastrointestinal Oncology, UT-MD Anderson Cancer Center, Houston, TX, USA

Interventional Oncology

Posted on
Guest Editors: David C. Madoff, MD. Yale School of Medicine, New Haven, CT USA.Julius Chapiro, MD, Yale School of Medicine, New Haven, CT USA; Uei Pua, MBBS. Tan Tock Seng Hospital, National University of Singapore, Singapore

Molecular Markers in Colorectal Cancer

Posted on
Guest Editors: Yun Shin Chun, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Michael D’Angelica, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Gallbladder Cancer

Posted on
Guest Editor: Ghassan K. Abou-Alfa, MD, MBA, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Medical College at Cornell University, New York, NY, USA.

Genetic Features of Pancreatic Cancer

Posted on
Guest Editors: Jin He, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Zhi-Gang Zhang, State Key Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute Shanghai Jiao Tong University, Shanghai 200127, China.
Xianjun Yu, Department of Pancreatic & Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Shanghai Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China.

Vol 8, No 1 (February 2019): Chinese Clinical Oncology (Recent Advances in Cutaneous T Cell Lymphoma)

Posted on
Guest Editors: Pierluigi Porcu, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson Health, Thomas Jefferson University, Philadelphia, USA.
Joya Sahu, Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Wenyin Shi, Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.

Vol 7, No 6 (December 2018): Chinese Clinical Oncology (Neoadjuvant Therapy for Ovarian Cancer)

Posted on
Guest Editor: Evgeny N. Imyanitov; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, St.-Petersburg, Russia; Department of Oncology, I.I. Mechnikov North-Western Medical University, St.-Petersburg, Russia; Department of Oncology, St.-Petersburg State University, St.-Petersburg, Russia.

Vol 6, No 5 (October 2017): Chinese Clinical Oncology (Esophagus Cancer-Guest Editors: Geoffrey Y. Ku, David H. Ilson)

Posted on
Guest Editors: Geoffrey Y. Ku, MD, Assistant Attending physician, Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
David H. Ilson, MD, PhD, Attending physician, Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.

Vol 6, Supplement 2 (September 2017): Chinese Clinical Oncology (Advances in Stereotactic Radio Surgery-Guest Editors: Kevin L. M. Chua, David B. H. Tan, Melvin. L. K. Chua, Simon S. Lo)

Posted on
Guest Editors: Kevin L. M. Chua, Division of Radiation Oncology, National Cancer Centre (NCCS), Singapore, Singapore.
David B. H. Tan, Division of Radiation Oncology, National Cancer Centre (NCCS), Singapore, Singapore.
Melvin. L. K. Chua, Division of Radiation Oncology, National Cancer Centre (NCCS), Singapore, Singapore; Oncology Academic Program, Duke-NUS Graduate Medical School (Duke-NUS), Singapore, Singapore.
Simon S. Lo, Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington, USA.

Vol 6, Supplement 1 (July 2017): Chinese Clinical Oncology (Contemporary and Future Treatment for Meningioma-Guest Editors: Matthias Preusser, Priscilla Brastianos, Helen A Shih)

Posted on
Guest Editors: Matthias Preusser, MD, Department of Medicine I, Comprehensive Cancer Center CNS Unit (CCC-CNS), Medical University of Vienna, Wien, Austria.
Priscilla Brastianos, MD, Departments of Medicine and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Helen A Shih, MD, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.

Vol 6, No 3 (June 2017): Chinese Clinical Oncology (Pancreas Adenocarcinoma-Part 1-Guest Editors: Eileen M. O’Reilly, Lei Zheng)

Posted on
Guest Editors: Eileen M. O’Reilly, MD. Associate Director, David M. Rubenstein Center for Pancreatic Cancer; Attending Physician, Member, Memorial Sloan Kettering Cancer Center; Professor of Medicine, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, USA; Lei Zheng, MD, PhD. Departments of Oncology, Surgery, The Sidney Kimmel Cancer Center, The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care; The Sol Goldman Pancreatic Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Vol 5, No 3 (June 2016): Multidisciplinary Management of Breast Cancer-Guest Editors: Charles M. Balch, Ning Liao, Kelly K. Hunt

Posted on
Guest Editors: Ning Liao, MD. Guangdong General Hospital and Cancer Center, Guangzhou 510080, China; Kelly K. Hunt, MD. University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Charles M. Balch, MD. University of Texas MD Anderson Cancer Center, Houston, Texas, USA; University of Texas Southwestern Medical Center, Dallas, Texas, USA

Vol 5, No 2 (April 2016): Nasopharyngeal Carcinoma-Guest Editors: Joseph Wee, Yoke-Lim Soong, Melvin Chua

Posted on
Guest Editors:Joseph Tien Seng Wee, Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Graduate Medical School, Singapore; Yoke Lim Soong, Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Graduate Medical School, Singapore; Melvin Lee Kiang Chua, Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Graduate Medical School, Singapore

Vol 4, No 1 (March 2015):Lymphoma - Guest Editors: Bruce D. Cheson and Jun Zhu

Posted on
Guest Editors: Bruce D. Cheson, MD. Professor of Medicine, Deputy Chief, Hematology-Oncology, Head of Hematology, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington DC 20007, USA.
Jun Zhu. Professor of Medical Oncology, Chief, Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing 100142, China.

Vol 3, No 2 (June 2014): The Changing World of Drug Development

Posted on
Guest Editor: Christian Dittrich, Ludwig Boltzmann Institute for Applied Cancer Research—LB Cluster Translational Oncology, Center for Oncology and Hematology, Kaiser Franz Josef-Spital, Vienna, Austria; European Organisation for Research and Treatment of Cancer (EORTC)-New Drug Advisory Committee (NDAC), Brussels, Belgium.